VTVT - vTv Therapeutics Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue2916345191,549
Cost of Revenue-45,74829,58418,729
Gross Profit291-45,114-29,065-17,180
Operating Expenses
Research Development39,64039,64039,64039,640
Selling General and Administrative11,3339,9069,07711,717
Non Recurring----
Others----
Total Operating Expenses50,97355,65438,66130,446
Operating Income or Loss-50,682-55,020-38,142-28,897
Income from Continuing Operations
Total Other Income/Expenses Net-3,165-333-2,965-7,204
Earnings Before Interest and Taxes-50,682-55,020-38,142-28,897
Interest Expense-3,092-398-1,775-6,013
Income Before Tax-53,847-55,353-41,107-36,101
Income Tax Expense800---
Minority Interest131,440122,515161,531161,531
Net Income From Continuing Ops-54,647-55,353-41,107-36,101
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-16,144-16,352-27,498-36,101
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-16,144-16,352-27,498-36,101